PHENEXPECT CD SYRUP

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

Drug Type

Therapeutic

Forensic Class

Pharmacy Only

HSA Singapore Classification

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05FB01

ATC Item Name

cough suppressants and mucolytics

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

ICM PHARMA PTE. LTD.

Active Ingredients

Ingredient Name

AMMONIUM CHLORIDE

Strength

135 mg/5 ml

Drug MonographAmmonium chloride

Ingredient Name

CODEINE PHOSPHATE

Strength

5.7 mg/5 ml

Drug MonographCodeine

Ingredient Name

DIPHENHYDRAMINE HCl

Strength

12.5 mg/5 ml

Drug MonographDiphenhydramine

AI-Powered Research

Premium Access

Regulatory Information

Regulatory Responsibility

Product Classification

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal